Homeobox A7 promotes esophageal squamous cell carcinoma progression through C‐C motif chemokine ligand 2‐mediated tumor‐associated macrophage recruitment
Cancer Science · 2023
DOI: 10.1111/cas.15842 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Anqi Feng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Changzhou Medical Center, Nanjing Medical University, Top-level Clinical Discipline Project of Shanghai Pudong, National Natural Science Foundation of China.
Abstract (Originalsprache)
Homeobox A7 (HOXA7) plays essential roles in multiple malignancies and was reported to be overexpressed in esophageal squamous cell carcinoma (ESCC). However, its functions in the ESCC tumor microenvironment remain to be explored. In this study, we showed that HOXA7 was overexpressed in ESCC among HOXA family members and correlated with tumor‐associated macrophage (TAM) infiltration both in The Cancer Genome Atlas database and ESCC clinical samples. Moreover, transactivation of C‐C motif chemokine ligand 2 (CCL2) by HOXA7 was identified (real‐time quantitative PCR [RT‐qPCR], western blot analysis, ELISA, and ChIP‐qPCR), which was detected to drive chemotaxis and M2 polarization of macrophages both in vitro (Transwell assay) and in vivo (xenograft tumors models). In addition, CCL2 triggers macrophage expression of epidermal growth factor (EGF) (RT‐qPCR and ELISA), which promotes tumor proliferation and metastasis by activating its receptor EGFR. In addition, EGF‐induced ESCC cell proliferation and migration can be abrogated by HOXA7 knockdown (CCK‐8 proliferation assay, EdU fluorescence, and Transwell assay). These results indicate a novel mechanistic role of HOXA7 in the cross‐talk between ESCC and TAMs, which could be an underlying therapeutic target for ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Nanjing, China.
- Department of Pathology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Anqi Feng, Lingnan He
Förderung
- Changzhou Medical Center, Nanjing Medical University
- Top-level Clinical Discipline Project of Shanghai Pudong
- National Natural Science Foundation of China
- Shanghai Committee of Science and Technology
Zitieren
APA
Feng, A., He, L., Jiang, J., Chu, Y., Zhang, Z., Fang, K., Wang, Z., Li, Z., Sun, M., Zhao, Z., Shi, J., Zhang, L., Chen, T., & Xu, M. (2023). Homeobox A7 promotes esophageal squamous cell carcinoma progression through C‐C motif chemokine ligand 2‐mediated tumor‐associated macrophage recruitment. Cancer Science. https://doi.org/10.1111/cas.15842
Vancouver
Feng A, He L, Jiang J, Chu Y, Zhang Z, Fang K, et al. Homeobox A7 promotes esophageal squamous cell carcinoma progression through C‐C motif chemokine ligand 2‐mediated tumor‐associated macrophage recruitment. Cancer Science. 2023. doi:10.1111/cas.15842
BibTeX
@article{Feng2023,
author = {Feng, Anqi and He, Lingnan and Jiang, Jiakai and Chu, Yuan and Zhang, Zehua and Fang, Kang and Wang, Zeyu and Li, Zhaoxing and Sun, Mingchuang and Zhao, Ziying and Shi, Jianing and Zhang, Li and Chen, Tao and Xu, Meidong},
title = {Homeobox A7 promotes esophageal squamous cell carcinoma progression through C‐C motif chemokine ligand 2‐mediated tumor‐associated macrophage recruitment},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15842}
}
EUVIMED